Takeaways: CDA‑AMC’s positive, conditional reimbursement recommendation for Nucala (mepolizumab) in adults with COPD and raised blood eosinophils who remain uncontrolled on ICS/LABA/LAMA triple therap...
Takeaways: The expanded approval of Lynkuet for AET‑related VMS gives Canadian oncologists and breast cancer patients the first non‑hormonal, evidence‑based option specifically indicated for...
Jamieson Wellness to be acquired by Kirin in C$2.5 billion transaction Jamieson Wellness announced that it has entered into a definitive agreement to be acquired by Kirin Holdings Company for C$45.75 ...
Takeaways: Light AI’s Health Canada Class II license for QuickScan Strep A clears the way to commercialize an AI‑based clinical decision support tool that analyzes digital throat images to h...
Takeaways: By placing TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster ...
Takeaways: Slenyto gives Canadian clinicians a prescription, extended‑release melatonin specifically studied for children and teens (ages 2 to <18) with autism spectrum disorder and/or Smith‑Mageni...
Takeaways: DeltaSleep’s Notte Series gives Canadian clinics and patients a locally made, Health Canada–licensed CPAP/APAP/BiPAP option that runs very quietly (≤26 dB) and sends therapy data to a Canad...
Takeaways: Itovebi’s addition to Québec’s RAMQ list means eligible patients with advanced HR‑positive, HER2‑negative, PIK3CA‑mutated breast cancer can now access a targeted pill that, in the INAVO120 ...
Takeaways: Grey Matter’s focused ultrasound platform aims to offer a non‑invasive option for people whose depression hasn’t improved with medications or therapy, by precisely stimulating deep brain ci...
Takeaways: Bracco’s VueJect is the first dedicated injector for cardiac ultrasound contrast, so it can make echocardiograms with Lumason/SonoVue more consistent, less dependent on who is doing the inj...